PACS Group (PACS) Stock Price, News & Analysis

Company Overview

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Key Stats

• Today's Range: $11.20 to $12.09
• 50-Day Range: $7.70 to $12.93
• 52-Week Range: $7.50 to $43.92
• Volume: 953,845 shs
• Average Volume: 646,942 shs
• Market Capitalization: $1.83 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $31.00
• Consensus Rating: Moderate Buy

PACS Group Stock Analysis - MarketRank™

PACS Group scored higher than 63% of companies evaluated by MarketBeat, and ranked 421st out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

PACS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

PACS Group has a consensus price target of $31.00, representing about 163.4% upside from its current price of $11.77.

Amount of Analyst Coverage

PACS Group has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 76.24%

Earnings Growth

Earnings for PACS Group are expected to grow by 76.24% in the coming year, from $1.01 to $1.78 per share.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.62% of the float of PACS Group has been sold short.

Short Interest Ratio / Days to Cover

PACS Group has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PACS Group has recently increased by 3.60%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PACS Group does not currently pay a dividend.

Dividend Growth

PACS Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.62% of the float of PACS Group has been sold short.

Short Interest Ratio / Days to Cover

PACS Group has a short interest ratio ("days to cover") of 3.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PACS Group has recently increased by 3.60%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.47

News Sentiment

PACS Group has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for PACS Group this week, compared to 7 articles on an average week.

Search Interest

19 people have searched for PACS on MarketBeat in the last 30 days.

MarketBeat Follows

4 people have added PACS Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PACS Group insiders have not sold or bought any company stock.

PACS Stock Analysis - Frequently Asked Questions

How have PACS shares performed this year?

PACS Group's stock was trading at $13.11 on January 1st, 2025. Since then, PACS stock has decreased by 10.2% and is now trading at $11.77.

How were PACS Group's earnings last quarter?

PACS Group, Inc. (NYSE:PACS) announced its quarterly earnings results on Monday, August, 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by $0.42. PACS Group's quarterly revenue was up 29.1% compared to the same quarter last year.
Read the conference call transcript.

When did PACS Group IPO?

PACS Group (PACS) raised $450 million in an initial public offering (IPO) on Thursday, April 11th 2024. The company issued 21,428,572 shares at a price of $21.00 per share.

Who are PACS Group's major shareholders?

Top institutional investors of PACS Group include JPMorgan Chase & Co. (0.80%), Ameriprise Financial Inc. (0.74%), Geode Capital Management LLC (0.62%) and Balyasny Asset Management L.P. (0.53%). Insiders that own company stock include Jason Hulse Murray and Jacqueline Millard.
View institutional ownership trends.

How do I buy shares of PACS Group?

Shares of PACS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PACS Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PACS Group investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Visa (V).

Company Calendar

• Last Earnings: 8/12/2024
• Today: 9/18/2025
• Next Earnings (Estimated): 9/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:PACS
• Previous Symbol: NYSE:PACS
• CIK: 2001184
• Web: pacs.com
• Phone: 801-447-9829
• Fax: N/A
• Employees: 32,433
• Year Founded: N/A

Price Target and Rating

• Average Price Target for PACS Group: $31.00
• High Price Target: $50.00
• Low Price Target: $18.00
• Potential Upside/Downside: +176.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.80
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $3.11 billion
• Price / Sales: 0.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 152,400,000
• Free Float: N/A
• Market Cap: $1.71 billion
• Optionable: Optionable
• Beta: 0.89